HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Reiji Yoshimura Selected Research

Fluvoxamine (Luvox)

1/2014Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients.
1/2009A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
8/2007Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa.
6/2006Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.
1/2003Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea.
1/2002Interaction between fluvoxamine and cotinine or caffeine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Reiji Yoshimura Research Topics

Disease

27Major Depressive Disorder (Major Depressive Disorders)
09/2015 - 01/2002
27Schizophrenia (Dementia Praecox)
03/2015 - 03/2003
5Depressive Disorder (Melancholia)
11/2010 - 01/2007
4Mood Disorders (Mood Disorder)
03/2013 - 07/2010
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2013 - 12/2008
4Bipolar Disorder (Mania)
03/2013 - 10/2006
4Anxiety Disorders (Anxiety Disorder)
08/2010 - 09/2007
2Atrophy
08/2015 - 11/2010
2Hyperprolactinemia
02/2013 - 03/2012
2Tobacco Use Disorder (Nicotine Dependence)
04/2012 - 04/2010
1Genetic Predisposition to Disease (Genetic Predisposition)
08/2015
1Substance-Related Disorders (Drug Abuse)
01/2014
1Neurobehavioral Manifestations
01/2014
1Gambling (Pathological Gambling)
01/2014
1Personality Disorders (Personality Disorder)
01/2014
1Brain Injuries (Brain Injury)
01/2013
1Polyarteritis Nodosa (Periarteritis Nodosa)
01/2012
1Coronary Disease (Coronary Heart Disease)
10/2011
1Meige Syndrome
01/2011
1Dysthymic Disorder
11/2010
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
04/2010
1Sleep Initiation and Maintenance Disorders (Insomnia)
08/2009
1Alcoholism (Alcohol Abuse)
01/2009
1Chorea (Rheumatic Chorea)
01/2009
1Tics (Tic)
01/2009
1Tourette Syndrome (Tourette's Syndrome)
01/2009
1Somatoform Disorders (Somatoform Disorder)
06/2008
1Burning Mouth Syndrome (Syndrome, Burning Mouth)
06/2008
1Delirium
09/2007
1Bulimia Nervosa
08/2007
1Serotonin Syndrome (Syndrome, Serotonin)
01/2007
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
06/2006
1Psychotic Disorders (Schizoaffective Disorder)
03/2005
1Paranoid Schizophrenia (Delusional Disorder)
03/2005
1Nausea
01/2003

Drug/Important Bio-Agent (IBA)

24Brain-Derived Neurotrophic Factor (BDNF)IBA
08/2015 - 06/2006
12Risperidone (Risperdal Consta)FDA LinkGeneric
01/2014 - 03/2003
8Homovanillic AcidIBA
01/2015 - 03/2003
8MethoxyhydroxyphenylglycolIBA
01/2015 - 03/2005
8Serotonin Uptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
06/2014 - 01/2003
8Antipsychotic Agents (Antipsychotics)IBA
01/2014 - 10/2006
7Paroxetine (Paxil)FDA LinkGeneric
06/2014 - 01/2003
7aripiprazole (Abilify)FDA Link
06/2014 - 01/2009
6olanzapine (Zyprexa)FDA Link
06/2014 - 01/2007
6Fluvoxamine (Luvox)FDA LinkGeneric
01/2014 - 01/2002
6Serotonin (5 Hydroxytryptamine)IBA
09/2013 - 09/2007
4Caffeine (No Doz)FDA LinkGeneric
12/2011 - 01/2002
4gamma-Aminobutyric Acid (GABA)IBA
12/2010 - 07/2009
3Biological Markers (Surrogate Marker)IBA
03/2013 - 02/2010
3CatecholaminesIBA
12/2012 - 01/2007
3Antidepressive Agents (Antidepressants)IBA
12/2012 - 01/2007
3Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2011 - 11/2009
2duloxetine (Cymbalta)FDA Link
01/2015 - 04/2014
2Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
01/2015 - 01/2014
2Norepinephrine (Noradrenaline)FDA LinkGeneric
04/2014 - 09/2007
2Interleukin-6 (Interleukin 6)IBA
09/2013 - 11/2010
2Sertraline (Zoloft)FDA LinkGeneric
12/2012 - 06/2011
2serotonin 6 receptorIBA
08/2010 - 07/2010
2Nerve Growth Factors (Neurotrophins)IBA
01/2009 - 01/2009
2SASIBA
06/2005 - 03/2005
2CotinineIBA
03/2005 - 01/2002
1Valine (L-Valine)FDA Link
09/2015
1catechol (pyrocatechol)IBA
09/2015
1TransferasesIBA
09/2015
1Hydrocortisone (Cortisol)FDA LinkGeneric
09/2015
1valylvaline (Val-Val)IBA
01/2015
1LithiumIBA
06/2014
16-bromo-2-naphthyl sulfate (BNS)IBA
01/2014
1AD 5423 (blonanserin)IBA
01/2014
1InterleukinsIBA
09/2013
1Valproic Acid (Valproate, Semisodium)FDA LinkGeneric
03/2013
15-HT1A Serotonin ReceptorIBA
03/2013
1shakuyaku-kanzoh-tohIBA
02/2013
1MelatoninIBA
12/2012
1GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA
12/2012
15,6,7,8-tetrahydrobiopterin (tetrahydrobiopterin)FDA Link
12/2012
1mirtazapine (Rexer)FDA LinkGeneric
09/2012
1Glutamine (L-Glutamine)FDA Link
01/2012
1Glutamic Acid (Glutamate)FDA Link
01/2012
1UbiquitinIBA
09/2011
1perospironeIBA
01/2011
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
09/2010
1sigma-1 receptor (receptor 1, sigma)IBA
06/2010
1tyramine-deoxysorbitolIBA
04/2010
1varenicline (Chantix)FDA Link
04/2010
1nicotinic receptor alpha4beta2IBA
04/2010
1NicotineFDA Link
04/2010
1milnacipran (Ixel)FDA Link
11/2009
1BenzodiazepinesIBA
08/2009
1Protons (Proton)IBA
07/2009
1TabletsIBA
01/2009
1F 4 (F-4)IBA
12/2008
1Dopamine (Intropin)FDA LinkGeneric
10/2008
1glycogen synthase kinase 3 betaIBA
10/2008
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
09/2007
1Trazodone (Trittico)FDA LinkGeneric
09/2007
1MianserinIBA
09/2007
1Lorazepam (Ativan)FDA LinkGeneric
06/2005

Therapy/Procedure

4Polypharmacy
03/2015 - 06/2012